Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C-Reference-Cited by-同舟云学术

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C

Published:2012-06 Issue:6 Volume:23 Page:1531-1536
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Price T.J.,Zannino D.,Wilson K.,Simes R.J.,Cassidy J.,Van Hazel G.A.,Robinson B.A.,Broad A.,Ganju V.,Ackland S.P.,Tebbutt N.C.

Funder

unconditional grant from Roche

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/6/1531/402751/mdr488.pdf

Reference13 articles.

1. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden;Edwards;Cancer,2002

2. Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials;Folprecht;Ann Oncol,2004

3. Co-morbidities alone do not explain the under treatment of colorectal cancer in older patients: a French population base study;Quipourt;J Am Geriatr Soc,2011

4. Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients;Poole;Cancer Chemother Pharmacol,2002

5. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab;Scappaticci;J Natl Cancer Inst,2007

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC;Frontiers in Surgery;2024-06-14

2. Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis;Annals of Hematology;2024-02-10

3. Evaluation of Apatinib-Related Hypertension and Identification of Clinical Risk Factors;Journal of Clinical Pharmacy and Therapeutics;2024-01-25

4. Is Older Age an Independent Prognostic Factor of Survival in Metastatic Colorectal Cancer?;Oncology;2024-01-17

5. Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta‐analysis;Cancer Medicine;2023-12